Document Detail


Review of controlled research on the transcendental meditation program and cardiovascular disease. Risk factors, morbidity, and mortality.
MedLine Citation:
PMID:  15316306     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Because of growing evidence for stress as a major factor contributing to cardiovascular disease (CVD), techniques of meditation are being increasingly used. The Transcendental Meditation (TM) technique is distinct from other techniques of meditation not only in its origin and procedure, but also in the amount and breadth of research testing it. Evidence for its ability to reduce traditional and novel risk factors for CVD includes: 1) decreases in blood pressure, 2) reduced use of tobacco and alcohol, 3) lowering of high cholesterol and lipid oxidation, and 4) decreased psychosocial stress. Changes expected to result from reducing these risk factors, namely, reversal of atherosclerosis, reduction of myocardial ischemia and left ventricular hypertrophy, reduced health insurance claims for CVD, and reduced mortality, also have been found with TM practice. Research on mechanisms suggests that some of the CVD-related benefits as a result of this technique could arise from normalization of neuroendocrine systems whose function has been distorted by chronic stress. Further randomized clinical trials are in progress with a focus on underserved minority populations.
Authors:
Kenneth G Walton; Robert H Schneider; Sanford Nidich
Related Documents :
1756026 - Recent evidence for the involvement of catecholamines and of macrophages in atheroscler...
1987996 - High density lipoproteins and coronary atherosclerosis. a strong inverse relation with ...
10494346 - Heparin-mediated extracorporeal ldl/fibrinogen precipitation--h.e.l.p.--in coronary and...
24469346 - Lateral medullary infarction with ipsilateral hemiparesis, lemniscal sensation loss and...
4028596 - Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate w...
1711966 - Mechanisms of sudden cardiac death.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Cardiology in review     Volume:  12     ISSN:  1061-5377     ISO Abbreviation:  Cardiol Rev     Publication Date:    2004 Sep-Oct
Date Detail:
Created Date:  2004-08-18     Completed Date:  2006-07-14     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  9304686     Medline TA:  Cardiol Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  262-6     Citation Subset:  IM    
Affiliation:
Center for Natural Medicine and Prevention, College of Maharishi Vedic Medicine, Maharishi University of Management, Fairfield, Iowa, USA. kwalton@mum.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure
Cardiovascular Diseases / epidemiology*,  mortality,  physiopathology,  therapy*
Controlled Clinical Trials as Topic
Health Knowledge, Attitudes, Practice
Humans
Meditation*
Morbidity
Program Development
Risk Factors
Grant Support
ID/Acronym/Agency:
IP50AT00082-01/AT/NCCAM NIH HHS; P50 AT000082-04/AT/NCCAM NIH HHS; P50 AT000082-05/AT/NCCAM NIH HHS; P50 AT000082-05S1/AT/NCCAM NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clopidogrel--statin interaction.
Next Document:  Atherosclerosis and systemic lupus erythematosus.